MICHAEL ALAN LOVETT, MD
Osteopathic Medicine at 120, Los Angeles, CA
License number
California G42965
Category
Osteopathic Medicine
Type
Infectious Disease
Address
Address
200 120Th St, Los Angeles, CA 90095
Phone
(310) 825-6301
(310) 825-2482
(310) 825-2482
Personal information
See more information about MICHAEL ALAN LOVETT at radaris.comName
Address
Phone
40161 Dixie Dr, Hemet, CA 92543
4435 Arizona St APT Q, San Diego, CA 92116
470 44Th St, Oakland, CA 94609
PO Box 1895, Glen Ellen, CA 95442
7105 Predial Way, Sacramento, CA 95842
Professional information
See more information about MICHAEL ALAN LOVETT at trustoria.com
Michael Alan Lovett, Los Angeles CA
Michael Alan Lovett, Los Angeles CA
Specialties:
Internal Medicine, Infectious Disease
Work:
Ucla Medical Group-W LA
200 Medical Plz, Los Angeles, CA 90024
200 Medical Plz, Los Angeles, CA 90024
Education:
University of California at San Diego (1976)
Dr. Michael A Lovett, Los Angeles CA - MD (Doctor of Medicine)
Dr. Michael A Lovett, Los Angeles CA - MD (Doctor of Medicine)
Specialties:
Infectious Disease Medicine
Address:
UCLA Medical Center-INF
10833 Le Conte Ave, Los Angeles 90095
(310) 825-7225 (Phone)
200 Medical Plz Way, Los Angeles 90095
(310) 825-7225 (Phone)
10833 Le Conte Ave, Los Angeles 90095
(310) 825-7225 (Phone)
200 Medical Plz Way, Los Angeles 90095
(310) 825-7225 (Phone)
Languages:
English
Hospitals:
UCLA Medical Center-INF
10833 Le Conte Ave, Los Angeles 90095
200 Medical Plz Way, Los Angeles 90095
Parkland Health Center - Bonne Terre
7245 Raider Rd, Bonne Terre 63628
10833 Le Conte Ave, Los Angeles 90095
200 Medical Plz Way, Los Angeles 90095
Parkland Health Center - Bonne Terre
7245 Raider Rd, Bonne Terre 63628
Education:
Medical School
University Of California, San Diego, School Of Medicine
Graduated: 1976
Mass Gen Hospital
University Of California, San Diego, School Of Medicine
Graduated: 1976
Mass Gen Hospital
Methods For Isolating T. Pallidum Rare Outer Membrane Proteins
Methods For Isolating T. Pallidum Rare Outer Membrane Proteins
US Patent:
6677439, Jan 13, 2004
Filed:
Oct 13, 1998
Appl. No.:
09/172070
Inventors:
David R. Blanco - Beverly Hills CA
James N. Miller - Northbridge CA
Michael A. Lovett - Los Angeles CA
Cheryl I. Champion - Culver City CA
James N. Miller - Northbridge CA
Michael A. Lovett - Los Angeles CA
Cheryl I. Champion - Culver City CA
Assignee:
The Regents of the University of California - Oakland CA
International Classification:
C07K 100
US Classification:
530412, 530350, 435 691, 435 6, 435 911, 435 915, 435170, 435 795, 435 71, 536 231, 536 243, 4242621, 514263
Abstract:
Antigenic rare outer membrane proteins of Spirochaetaceae are obtained from organisms extracted from infected tissue by a novel process of isolation utilizing a discontinuous Ficoll gradient separation, release of outer membrane in a low isotonic and low pH buffer and identification of outer membrane by use of a lipid soluble dye. Four antigenic rare outer membrane proteins of subsp. useful in diagnosis and prophylaxis of syphilis are provided. Also provided is the amino acid sequence of a rare outer membrane protein of subsp. and the nucleotide sequence encoding it.
Cloned Leptospira Outer Membrane Protein
Cloned Leptospira Outer Membrane Protein
US Patent:
6685945, Feb 3, 2004
Filed:
Aug 19, 1997
Appl. No.:
08/914350
Inventors:
David A. Haake - Culver City CA
David R. Blanco - Beverly Hills CA
Cheryl I. Champion - Culver City CA
Michael A. Lovett - Los Angeles CA
James N. Miller - Northridge CA
David R. Blanco - Beverly Hills CA
Cheryl I. Champion - Culver City CA
Michael A. Lovett - Los Angeles CA
James N. Miller - Northridge CA
Assignee:
The Regents of the University of California - Oakland CA
International Classification:
A61K 3902
US Classification:
4241901, 4242341, 530350, 530825, 430200
Abstract:
An antigenic preparation is provided which contains a 31 Kd outer membrane protein from Leptospira which can be used immunologically as a vaccine for leptospirosis caused by this organism.
Cloned Borrelia Burgdorferi Virulence Protein
Cloned Borrelia Burgdorferi Virulence Protein
US Patent:
5558993, Sep 24, 1996
Filed:
Jun 17, 1994
Appl. No.:
8/261825
Inventors:
Cheryl I. Champion - Culver City CA
Michael A. Lovett - Los Angeles CA
David A. Haake - Culver City CA
James N. Miller - Northridge CA
David R. Blanco - Northridge CA
Michael A. Lovett - Los Angeles CA
David A. Haake - Culver City CA
James N. Miller - Northridge CA
David R. Blanco - Northridge CA
Assignee:
The Regents of the University of California - Oakland CA
International Classification:
C07H 2102, C07H 2104, C12N 121, C12N 1570, C12P 2100, C12Q 168
US Classification:
435 6
Abstract:
A polynucleotide encoding a 17-kD virulence protein, called EppA, from Borrelia burgdorferi is provided. The protein encoded by the polynucleotide of the invention is useful immunologically as a vaccine for Lyme borreliosis caused by B. burgdorferi. Methods and kits for detection of EppA polynucleotide are also provided.
Nucleotide Sequences Of A T. Pallidum Rare Outer Membrane Protein
Nucleotide Sequences Of A T. Pallidum Rare Outer Membrane Protein
US Patent:
5821085, Oct 13, 1998
Filed:
Apr 23, 1997
Appl. No.:
8/842199
Inventors:
David R. Blanco - Beverly Hills CA
James N. Miller - Northridge CA
Michael A. Lovett - Los Angeles CA
Cheryl I. Champion - Culver City CA
James N. Miller - Northridge CA
Michael A. Lovett - Los Angeles CA
Cheryl I. Champion - Culver City CA
Assignee:
The Regents of the University of California - Oakland CA
International Classification:
C07H 2104, C12N 1500, C12N 1563, C12N 121
US Classification:
435 691
Abstract:
Antigenic rare outer membrane proteins of Spirochaetaceae are obtained from organisms extracted from infected tissue by a novel process of isolation utilizing a discontinuous Ficoll gradient separation, release of outer membrane in a low isotonic and low pH buffer and identification of outer membrane by use of a lipid soluble dye. Four antigenic rare outer membrane proteins of T. pallidum subsp. pallidum useful in diagnosis and prophylaxis of syphilis are provided. Also provided is the amino acid sequence of a rare outer membrane protein of T. pailidum subsp. pallidum and the nucleotide sequence encoding it.
Nucleotide Sequences Of T. Pallidum Rare Outer Membrane Protein
Nucleotide Sequences Of T. Pallidum Rare Outer Membrane Protein
US Patent:
5753459, May 19, 1998
Filed:
Jan 23, 1996
Appl. No.:
8/599480
Inventors:
David R. Blanco - Beverly Hills CA
James N. Miller - Northridge CA
Michael A. Lovett - Los Angeles CA
Cheryl I. Champion - Culver City CA
Paul J. Tempst - New York NY
James N. Miller - Northridge CA
Michael A. Lovett - Los Angeles CA
Cheryl I. Champion - Culver City CA
Paul J. Tempst - New York NY
Assignee:
The Regents of the University of California - Oakland CA
Sloan-Kettering Institute for Cancer Research - New York NY
Sloan-Kettering Institute for Cancer Research - New York NY
International Classification:
C12P 2100, C07H 2104, C07H 2102
US Classification:
435 691
Abstract:
Antigenic rare outer membrane proteins of Spirochaetaceae are obtained from organisms extracted from infected tissue by a novel process of isolation utilizing a discontinuous Ficoll gradient separation, release of outer membrane in a low isotonic and low pH buffer and identification of outer membrane by use of a lipid soluble dye. Four antigenic rare outer membrane proteins of T. pallidum subsp. pallidum useful in diagnosis and prophylaxis of syphilis are provided. Also provided are the amino acid sequences of two rare outer membrane proteins of T. pallidum subsp. pallidum, called TROMP 1 and TROMP 2, and the nucleotide sequences encoding them.
Cloned Leptospira Outer Membrane Protein
Cloned Leptospira Outer Membrane Protein
US Patent:
2003016, Aug 28, 2003
Filed:
Dec 17, 2002
Appl. No.:
10/322391
Inventors:
David Haake - Culver City CA, US
David Blanco - Beverly Hills CA, US
Cheryl Champion - Culver City CA, US
Michael Lovett - Los Angeles CA, US
James Miller - Northridge CA, US
David Blanco - Beverly Hills CA, US
Cheryl Champion - Culver City CA, US
Michael Lovett - Los Angeles CA, US
James Miller - Northridge CA, US
Assignee:
THE REGENTS OF THE UNIVERSITY OF CALIFORNIA, a California corporation
International Classification:
C12Q001/68, G01N033/554, G01N033/569, C07K014/195, C07H021/04, C12N015/74
US Classification:
435/006000, 435/007320, 435/320100, 435/069300, 435/252300, 530/350000, 536/023500
Abstract:
An antigenic preparation is provided which contains a 31 Kd outer membrane protein from Leptospira which can be used immunologically as a vaccine for leptospirosis caused by this organism.
Cloned Borrelia Burgdorferi Virulence Protein
Cloned Borrelia Burgdorferi Virulence Protein
US Patent:
5854395, Dec 29, 1998
Filed:
Sep 24, 1996
Appl. No.:
8/719124
Inventors:
Cheryl I. Champion - Culver City CA
Michael A. Lovett - Los Angeles CA
David A. Haake - Culver City CA
James N. Miller - Northridge CA
David R. Blanco - Beverly Hills CA
Michael A. Lovett - Los Angeles CA
David A. Haake - Culver City CA
James N. Miller - Northridge CA
David R. Blanco - Beverly Hills CA
Assignee:
The Regents of the University of California - Oakland CA
International Classification:
C07K 14195
US Classification:
530350
Abstract:
The present invention provides EppA polypeptide, a Borrelia burgdorferi virulence protein. This 17-kD outer membrane protein has been designated EppA for exported plasmid protein A.
Cloned Leptospira Outer Membrane Protein
Cloned Leptospira Outer Membrane Protein
US Patent:
5658757, Aug 19, 1997
Filed:
Dec 20, 1994
Appl. No.:
8/362739
Inventors:
David A. Haake - Culver City CA
David R. Blanco - Beverly Hills CA
Cheryl I. Champion - Culver City CA
Michael A. Lovett - Los Angeles CA
James N. Miller - Northridge CA
David R. Blanco - Beverly Hills CA
Cheryl I. Champion - Culver City CA
Michael A. Lovett - Los Angeles CA
James N. Miller - Northridge CA
Assignee:
The Regents of the University of California - Oakland CA
International Classification:
C12N 1500, C12N 500, C12D 2106, C07H 1900
US Classification:
435 691
Abstract:
An antigenic preparation is provided which contains a 31 Kd outer membrane protein from Leptospira which can be used immunologically as a vaccine for leptospirosis caused by this organism.